Antimicrobial resistance in Escherichia coli (E. coli) is a major public health concern globally, driven by increased resistance to commonly used antimicrobial agents such as β-lactams and fluoroquinolones. The main goal of our research is to develop a machine learning framework to predict antimicrobial resistance in E. coli by integrating antimicrobial susceptibility testing data with genomic biomarker analysis. A dataset comprising 17,122 E. coli clinical isolates was obtained from the Bacterial and Viral Bioinformatics Resource Center (BV-BRC). After preprocessing, fivefold cross-validation was used to train and test five machine learning models: Random Forest, XGBoost, Support Vector Machine, Logistic Regression, and k-Nearest Neighbors. The highest-performing model was XGBoost, with 0.86 accuracy and 0.932 ROC-AUC, followed by Random Forest, with 0.82 accuracy and 0.89 ROC-AUC. Phylogenetic analysis revealed that resistant isolates clustered together relative to the reference genome of E. coli K-12 MG1655. Genomic biomarkers such as gyrA, parC, CTX-M-15, OXA-1, and various multidrug efflux pumps were identified by the Comprehensive Antibiotic Resistance Database (CARD) and ResFinder as significant resistance determinants in this study. In conclusion, this study demonstrates that combining antimicrobial susceptibility testing with machine learning and genomic biomarkers is a powerful framework for predicting antimicrobial resistance in E. coli.
Adeyemi et al. (Mon,) studied this question.